{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T23:07:49Z","timestamp":1780614469677,"version":"3.54.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:00:00Z","timestamp":1687737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:00:00Z","timestamp":1687737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008484","name":"BioMarin Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Collection of real-world evidence (RWE) is important in achondroplasia. Development of a prospective, shared, international resource that follows the principles of findability, accessibility, interoperability, and reuse of digital assets, and that captures long-term, high-quality data, would improve understanding of the natural history of achondroplasia, quality of life, and related outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The Europe, Middle East, and Africa (EMEA) Achondroplasia Steering Committee comprises a multidisciplinary team of 17 clinical experts and 3 advocacy organization representatives. The committee undertook an exercise to identify essential data elements for a standardized prospective registry to study the natural history of achondroplasia and related outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A range of RWE on achondroplasia is being collected at EMEA centres. Whereas commonalities exist, the data elements, methods used to collect and store them, and frequency of collection vary. The topics considered most important for collection were auxological measures, sleep studies, quality of life, and neurological manifestations. Data considered essential for a prospective registry were grouped into six categories: demographics; diagnosis and patient measurements; medical issues; investigations and surgical events; medications; and outcomes possibly associated with achondroplasia treatments.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Long-term, high-quality data are needed for this rare, multifaceted condition. Establishing registries that collect predefined data elements across age spans will provide contemporaneous prospective and longitudinal information and will be useful to improve clinical decision-making and management. It should be feasible to collect a minimum dataset with the flexibility to include country-specific criteria and pool data across countries to examine clinical outcomes associated with achondroplasia and different therapeutic approaches.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13023-023-02755-w","type":"journal-article","created":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T16:02:58Z","timestamp":1687795378000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Real-world evidence in achondroplasia: considerations for a standardized data set"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0683-9731","authenticated-orcid":false,"given":"Yasemin","family":"Alanay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Mohnike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00eas","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moeenaldeen","family":"AlSayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha M.","family":"Appelman-Dijkstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve","family":"Baujat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tawfeg","family":"Ben-Omran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Breyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Cormier-Daire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pernille Ax\u00e9l","family":"Gregersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Encarna","family":"Guill\u00e9n-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"H\u00f6gler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Maghnie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelda","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne","family":"Pimenta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Selicorni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Oliver","family":"Semler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Sigaudy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry","family":"Popkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Sabir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Noval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Sessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melita","family":"Irving","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,26]]},"reference":[{"key":"2755_CR1","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2147\/TACG.S51485","volume":"7","author":"PJ Ireland","year":"2014","unstructured":"Ireland PJ, Pacey V, Zankl A, Edwards P, Johnston LM, Savarirayan R. Optimal management of complications associated with achondroplasia. Appl Clin Genet. 2014;7:117\u201325.","journal-title":"Appl Clin Genet"},{"key":"2755_CR2","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S0140-6736(07)61090-3","volume":"370","author":"WA Horton","year":"2007","unstructured":"Horton WA, Hall JG, Hecht JT. Achondroplasia. The Lancet. 2007;370:162\u201372.","journal-title":"The Lancet"},{"key":"2755_CR3","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1002\/ajmg.a.61787","volume":"182","author":"PK Foreman","year":"2020","unstructured":"Foreman PK, van Kessel F, van Hoorn R, van den Bosch J, Shediac R, Landis S. Birth prevalence of achondroplasia: a systematic literature review and meta-analysis. Am J Med Genet A. 2020;182:2297\u2013316.","journal-title":"Am J Med Genet A"},{"key":"2755_CR4","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1038\/s41436-021-01165-2","volume":"23","author":"JE Hoover-Fong","year":"2021","unstructured":"Hoover-Fong JE, Alade AY, Hashmi SS, Hecht JT, Legare JM, Little ME, Liu C, McGready J, Modaff P, Pauli RM, et al. Achondroplasia Natural History Study (CLARITY): a multicenter retrospective cohort study of achondroplasia in the United States. Genet Med. 2021;23:1498\u2013505.","journal-title":"Genet Med"},{"key":"2755_CR5","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1542\/peds.2005-1440","volume":"116","author":"TL Trotter","year":"2005","unstructured":"Trotter TL, Hall JG, American Academy of Pediatrics Committee on G. Health supervision for children with achondroplasia. Pediatrics. 2005;116:771\u201383.","journal-title":"Pediatrics"},{"key":"2755_CR6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/MOP.0b013e328013e3d9","volume":"19","author":"EM Carter","year":"2007","unstructured":"Carter EM, Davis JG, Raggio CL. Advances in understanding etiology of achondroplasia and review of management. Curr Opin Pediatr. 2007;19:32\u20137.","journal-title":"Curr Opin Pediatr"},{"key":"2755_CR7","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1136\/jmg.35.9.705","volume":"35","author":"AG Hunter","year":"1998","unstructured":"Hunter AG, Bankier A, Rogers JG, Sillence D, Scott CI Jr. Medical complications of achondroplasia: a multicentre patient review. J Med Genet. 1998;35:705\u201312.","journal-title":"J Med Genet"},{"key":"2755_CR8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1136\/adc.2010.189092","volume":"97","author":"MJ Wright","year":"2012","unstructured":"Wright MJ, Irving MD. Clinical management of achondroplasia. Arch Dis Child. 2012;97:129\u201334.","journal-title":"Arch Dis Child"},{"key":"2755_CR9","doi-asserted-by":"publisher","first-page":"171","DOI":"10.4103\/picr.picr_62_21","volume":"12","author":"D Chodankar","year":"2021","unstructured":"Chodankar D. Introduction to real-world evidence studies. Perspect Clin Res. 2021;12:171\u20134.","journal-title":"Perspect Clin Res"},{"key":"2755_CR10","unstructured":"Administration USFD. Real-World Evidence. Real-world data (RWD) and real-world evidence (RWE) are playing an increasing role in health care decisions. U.S. Food & Drug Administration; 2020."},{"key":"2755_CR11","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1056\/NEJMsb1609216","volume":"375","author":"RE Sherman","year":"2016","unstructured":"Sherman RE, Anderson SA, Dal Pan GJ, Gray GW, Gross T, Hunter NL, LaVange L, Marinac-Dabic D, Marks PW, Robb MA, et al. Real-world evidence: what is it and what can it tell us? N Engl J Med. 2016;375:2293\u20137.","journal-title":"N Engl J Med"},{"key":"2755_CR12","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1002\/ajmg.a.61825","volume":"182","author":"E Okenfuss","year":"2020","unstructured":"Okenfuss E, Moghaddam B, Avins AL. Natural history of achondroplasia: a retrospective review of longitudinal clinical data. Am J Med Genet A. 2020;182:2540\u201351.","journal-title":"Am J Med Genet A"},{"key":"2755_CR13","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13023-021-01792-7","volume":"16","author":"SO Fredwall","year":"2021","unstructured":"Fredwall SO, Overland B, Berdal H, Berg S, Weedon-Fekjaer H, Lidal IB, Savarirayan R, Manum G. Obstructive sleep apnea in Norwegian adults with achondroplasia: a population-based study. Orphanet J Rare Dis. 2021;16:156.","journal-title":"Orphanet J Rare Dis"},{"key":"2755_CR14","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/ajmg.a.61289","volume":"179","author":"A Coi","year":"2019","unstructured":"Coi A, Santoro M, Garne E, Pierini A, Addor MC, Alessandri JL, Bergman JEH, Bianchi F, Boban L, Braz P, et al. Epidemiology of achondroplasia: a population-based study in Europe. Am J Med Genet A. 2019;179:1791\u20138.","journal-title":"Am J Med Genet A"},{"key":"2755_CR15","doi-asserted-by":"publisher","unstructured":"Legare JM, Liu C, Pauli RM, Alade AY, Hashmi SS, Campbell JW, Smid CJ, Modaff P, Little ME, Rodriguez-Buritica DF, et al. Achondroplasia Natural History Study (CLARITY): 60-year experience in cervicomedullary decompression in achondroplasia from four skeletal dysplasia centers. J Neurosurg Pediatr. 2021;1\u20137. https:\/\/doi.org\/10.3171\/2020.12.PEDS20715.","DOI":"10.3171\/2020.12.PEDS20715"},{"key":"2755_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-018-0972-6","volume":"14","author":"RM Pauli","year":"2019","unstructured":"Pauli RM. Achondroplasia: a comprehensive clinical review. Orphanet J Rare Dis. 2019;14:1.","journal-title":"Orphanet J Rare Dis"},{"key":"2755_CR17","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/bdra.23210","volume":"100","author":"K Simmons","year":"2014","unstructured":"Simmons K, Hashmi SS, Scheuerle A, Canfield M, Hecht JT. Mortality in babies with achondroplasia: revisited. Birth Defects Res A Clin Mol Teratol. 2014;100:247\u20139.","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"2755_CR18","first-page":"454","volume":"41","author":"JT Hecht","year":"1987","unstructured":"Hecht JT, Francomano CA, Horton WA, Annegers JF. Mortality in achondroplasia. Am J Hum Genet. 1987;41:454\u201364.","journal-title":"Am J Hum Genet"},{"key":"2755_CR19","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/cge.13542","volume":"97","author":"SO Fredwall","year":"2020","unstructured":"Fredwall SO, Maanum G, Johansen H, Snekkevik H, Savarirayan R, Lidal IB. Current knowledge of medical complications in adults with achondroplasia: a scoping review. Clin Genet. 2020;97:179\u201397.","journal-title":"Clin Genet"},{"key":"2755_CR20","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1136\/archdischild-2020-319625","volume":"106","author":"MS Cheung","year":"2021","unstructured":"Cheung MS, Irving M, Cocca A, Santos R, Shaunak M, Dougherty H, Siddiqui A, Gringras P, Thompson D. Achondroplasia Foramen Magnum Score: screening infants for stenosis. Arch Dis Child. 2021;106:180\u20134.","journal-title":"Arch Dis Child"},{"key":"2755_CR21","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.jpeds.2009.04.031","volume":"155","author":"M Ednick","year":"2009","unstructured":"Ednick M, Tinkle BT, Phromchairak J, Egelhoff J, Amin R, Simakajornboon N. Sleep-related respiratory abnormalities and arousal pattern in achondroplasia during early infancy. J Pediatr. 2009;155:510\u20135.","journal-title":"J Pediatr"},{"key":"2755_CR22","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1111\/j.1469-8749.2011.04050.x","volume":"53","author":"PJ Ireland","year":"2011","unstructured":"Ireland PJ, McGill J, Zankl A, Ware RS, Pacey V, Ault J, Savarirayan R, Sillence D, Thompson EM, Townshend S, et al. Functional performance in young Australian children with achondroplasia. Dev Med Child Neurol. 2011;53:944\u201350.","journal-title":"Dev Med Child Neurol"},{"key":"2755_CR23","first-page":"250","volume":"14","author":"S Afsharpaiman","year":"2013","unstructured":"Afsharpaiman S, Saburi A, Waters KA. Respiratory difficulties and breathing disorders in achondroplasia. Paediatr Respir Rev. 2013;14:250\u20135.","journal-title":"Paediatr Respir Rev"},{"key":"2755_CR24","doi-asserted-by":"publisher","first-page":"e20201010","DOI":"10.1542\/peds.2020-1010","volume":"145","author":"J Hoover-Fong","year":"2013","unstructured":"Hoover-Fong J, Scott CI, Jones MC, Committee On G. Health supervision for people with achondroplasia. Pediatrics. 2020;145:e20201010. https:\/\/doi.org\/10.1542\/peds.2020-1010.","journal-title":"Pediatrics"},{"key":"2755_CR25","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1111\/jocn.12531","volume":"23","author":"N Nishimura","year":"2014","unstructured":"Nishimura N, Hanaki K. Psychosocial profiles of children with achondroplasia in terms of their short stature-related stress: a nationwide survey in Japan. J Clin Nurs. 2014;23:3045\u201356.","journal-title":"J Clin Nurs"},{"key":"2755_CR26","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13023-018-0836-0","volume":"13","author":"MC Jansen-van der Weide","year":"2018","unstructured":"Jansen-van der Weide MC, Gaasterland CMW, Roes KCB, Pontes C, Vives R, Sancho A, Nikolakopoulos S, Vermeulen E, van der Lee JH. Rare disease registries: potential applications towards impact on development of new drug treatments. Orphanet J Rare Dis. 2018;13:154.","journal-title":"Orphanet J Rare Dis"},{"key":"2755_CR27","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s13023-019-1171-9","volume":"14","author":"S Witt","year":"2019","unstructured":"Witt S, Kolb B, Bloemeke J, Mohnike K, Bullinger M, Quitmann J. Quality of life of children with achondroplasia and their parents: a German cross-sectional study. Orphanet J Rare Dis. 2019;14:194.","journal-title":"Orphanet J Rare Dis"},{"key":"2755_CR28","first-page":"109","volume":"15","author":"S Witt","year":"2017","unstructured":"Witt S, Rohenkohl A, Bullinger M, Sommer R, Kahrs S, Klingebiel KH, Klingebiel R, Quitmann J. Understanding, assessing and improving health-related quality of life of young people with achondroplasia: a collaboration between a patient organization and academic medicine. Pediatr Endocrinol Rev. 2017;15:109\u201318.","journal-title":"Pediatr Endocrinol Rev"},{"key":"2755_CR29","doi-asserted-by":"publisher","first-page":"6166","DOI":"10.1080\/09638288.2021.1963853","volume":"44","author":"C Constantinides","year":"2022","unstructured":"Constantinides C, Landis SH, Jarrett J, Quinn J, Ireland PJ. Quality of life, physical functioning, and psychosocial function among patients with achondroplasia: a targeted literature review. Disabil Rehabil. 2022;44:6166\u201378. https:\/\/doi.org\/10.1080\/09638288.2021.1963853.","journal-title":"Disabil Rehabil"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02755-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-023-02755-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02755-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T20:46:20Z","timestamp":1702673180000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-023-02755-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,26]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2755"],"URL":"https:\/\/doi.org\/10.1186\/s13023-023-02755-w","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,26]]},"assertion":[{"value":"29 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"KM received support for the present manuscript from BioMarin Pharmaceutical; had a consulting agreement with Biomarin; received payment or honoraria for lectures, podcast from Biomarin; participated on a Data Safety Monitoring Board for QED; and was Vice chair of German Patient organization BKMF e.V. ON received speakers honoraria from Pfizer, Abbott, BioMarin; participated on a Data Safety Monitoring Board or Advisory Board for BioMarin; was an XLH registry steering committee member for KyowaKirin; and was on the ESPE program organizing committee. MA received support from medical writer, funding, and article processing fees from BioMarin; consulting fees, payment or honoraria, and support for attending meetings and\/or travel from BioMarin and participated on a Data Safety Monitoring Board or Advisory Board for BioMarin. NMA-D received an EU Health grant for the coordination of the European Registries for Rare Bone and Mineral Conditions. SB received support from medical writer, funding, and article processing fees from BioMarin; consulting fees, payment or honoraria, and support for attending meetings and\/or travel from BioMarin and participated on a Data Safety Monitoring Board or Advisory Board for BioMarin. VC-D received payment or honoraria from BioMarin Ipsen; and participated on a Data Safety Monitoring Board or Advisory Board for ULtragenyx-Mereo, QED-Propel, BioMarin. EG-N received support for the present manuscript, received payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events, and support for attending meetings from BioMarin Pharmaceutical; participated on a Data Safety Monitoring Board for BioMarin Pharmaceutical; and had a leadership or fiduciary role in other board, society, committee or advocacy group for AEGH. WH received consulting fees from BioMarin for an Advisory Service agreement. MM received grants or contracts from Pfizer, Novo Nordisk, Merck Serono; consulting fees and payment or honoraria from Pfizer, Novo Nordisk, Merck Serono, Sandoz, BioMarin and participated in a Data Safety Monitoring Board or Advisory Board for Pfizer. SM is an employee of BioMarin Pharmaceutical Inc. and owns stocks in the company. SC is an employee of BioMarin Europe, Ltd. and owns stock or stock options in the company. JP is an employee of BioMarin and owns stock or stock options in the company. AS received honoraria from BioMarin for participating in a Data Safety Monitoring Board. JOS received support for medical writing, funded by BioMarin; personal payment or honoraria for lectures from BioMarin. IS is an employee of BioMarin Pharmaceutical Inc. and holds stock or stock options in the company. MS received support for the present manuscript from the Associazione per l\u2019Informazione e lo Studio Dell\u2019Acondroplasia-ODV; two grants for members meeting from BioMarin payment or honoraria from BMRN VOXZOGO Launch Meeting 2021 and BioMarin Steering Committee Working Together with Patients; participated in the BioMarin Achondroplasia Management Guidelines and a BioMarin Advisory Board (Achondroplasia Care Pathway Survey Review); and is the unpaid president of AISAC ODV. MI received has received honoraria for consultancy services from BioMarin, QED Therapeutics, Pfizer\/Therachon, Sanofi, Ascendis, Alexionk, Kyowa Kirin, Innoskel and NovoNordisk. All other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"166"}}